Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 206

1.

Stability of tubular damage markers epidermal growth factor and heparin-binding EGF-like growth factor in urine.

Harskamp LR, Meijer E, van Goor H, Engels GE, Gansevoort RT.

Clin Chem Lab Med. 2019 Mar 5. pii: /j/cclm.ahead-of-print/cclm-2019-0152/cclm-2019-0152.xml. doi: 10.1515/cclm-2019-0152. [Epub ahead of print] No abstract available.

PMID:
30835251
2.

The optimal incubation time for in vitro hemocompatibility testing: Assessment using polymer reference materials under pulsatile flow with physiological wall shear stress conditions.

Blok SLJ, van Oeveren W, Engels GE.

J Biomed Mater Res B Appl Biomater. 2019 Jan 29. doi: 10.1002/jbm.b.34326. [Epub ahead of print]

PMID:
30697956
3.

Additional filtering of blood from a cell salvage device is not likely to show important additional benefits in outcome in cardiac surgery.

de Vries AJ, Vermeijden WJ, van Pelt LJ, van den Heuvel ER, van Oeveren W.

Transfusion. 2019 Mar;59(3):989-994. doi: 10.1111/trf.15130. Epub 2019 Jan 4.

PMID:
30610759
4.

Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.

Messchendorp AL, Meijer E, Boertien WE, Engels GE, Casteleijn NF, Spithoven EM, Losekoot M, Burgerhof JGM, Peters DJM, Gansevoort RT; DIPAK Consortium.

Kidney Int Rep. 2017 Oct 14;3(2):291-301. doi: 10.1016/j.ekir.2017.10.004. eCollection 2018 Mar.

5.

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.

Plomgaard AM, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Fumagalli M, Gluud C, Hagmann C, Hyttel-Sorensen S, Lemmers P, van Oeveren W, Pellicer A, Petersen TH, Pichler G, Winkel P, Greisen G.

PLoS One. 2017 Mar 22;12(3):e0173440. doi: 10.1371/journal.pone.0173440. eCollection 2017.

6.

Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate.

Ramsauer B, Engels GE, Graaff R, Sikole A, Arsov S, Stegmayr B.

BMC Nephrol. 2017 Jan 5;18(1):5. doi: 10.1186/s12882-016-0418-0.

7.

Hemostatic action of polyurethane foam with 55% polyethylene glycol compared to collagen and gelatin.

Broekema FI, van Oeveren W, Boerendonk A, Sharma PK, Bos RR.

Biomed Mater Eng. 2016 Aug 12;27(2-3):149-59. doi: 10.3233/BME-161578.

PMID:
27567771
8.

Stirred, shaken, or stagnant: What goes on at the blood-biomaterial interface.

Reviakine I, Jung F, Braune S, Brash JL, Latour R, Gorbet M, van Oeveren W.

Blood Rev. 2017 Jan;31(1):11-21. doi: 10.1016/j.blre.2016.07.003. Epub 2016 Jul 25. Review.

PMID:
27478147
9.

In vitro blood flow model with physiological wall shear stress for hemocompatibility testing-An example of coronary stent testing.

Engels GE, Blok SL, van Oeveren W.

Biointerphases. 2016 Sep 18;11(3):031004. doi: 10.1116/1.4958979.

PMID:
27435456
10.

In vitro hemocompatibility testing: The importance of fresh blood.

Blok SL, Engels GE, van Oeveren W.

Biointerphases. 2016 Jun 12;11(2):029802. doi: 10.1116/1.4941850.

PMID:
26872581
11.

Intraoperative cell salvage during cardiac surgery is associated with reduced postoperative lung injury.

Engels GE, van Klarenbosch J, Gu YJ, van Oeveren W, de Vries AJ.

Interact Cardiovasc Thorac Surg. 2016 Mar;22(3):298-304. doi: 10.1093/icvts/ivv355. Epub 2015 Dec 23.

12.

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.

Plomgaard AM, van Oeveren W, Petersen TH, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Franz A, Fumagalli M, Gluud C, Hagmann C, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Winkel P, Greisen G.

Pediatr Res. 2016 Apr;79(4):528-35. doi: 10.1038/pr.2015.266. Epub 2015 Dec 17.

13.

Tubular Injury Biomarkers to Detect Gentamicin-Induced Acute Kidney Injury in the Neonatal Intensive Care Unit.

Jansen D, Peters E, Heemskerk S, Koster-Kamphuis L, Bouw MP, Roelofs HM, van Oeveren W, van Heijst AF, Pickkers P.

Am J Perinatol. 2016 Jan;33(2):180-7. doi: 10.1055/s-0035-1563714. Epub 2015 Sep 7.

PMID:
26344007
14.

Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

Harskamp LR, Gansevoort RT, Boertien WE, van Oeveren W, Engels GE, van Goor H, Meijer E.

Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1749-56. doi: 10.2215/CJN.09941014. Epub 2015 Jul 31.

15.

Perioperative and bedside cerebral monitoring identifies cerebral injury after surgical correction of congenital aortic arch obstruction.

Algra SO, Schouten AN, Jansen NJ, van Oeveren W, Haas F, Groenendaal F, Lemmers PM, van Haastert IC, Toet MC, de Vries LS.

Intensive Care Med. 2015 Nov;41(11):2011-2. doi: 10.1007/s00134-015-3996-6. Epub 2015 Jul 28. No abstract available.

PMID:
26215683
16.

Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction.

Gerritsen KG, Leeuwis JW, Koeners MP, Bakker SJ, van Oeveren W, Aten J, Tarnow L, Rossing P, Wetzels JF, Joles JA, Kok RJ, Goldschmeding R, Nguyen TQ.

J Diabetes Res. 2015;2015:539787. doi: 10.1155/2015/539787. Epub 2015 Jun 15.

17.

Biomarkers of lung injury in cardiothoracic surgery.

Engels GE, van Oeveren W.

Dis Markers. 2015;2015:472360. doi: 10.1155/2015/472360. Epub 2015 Mar 17. Review.

18.

Corrigendum. The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients.

Arsov S, Trajceska L, van Oeveren W, Smit AJ, Dzekova P, Stegmayr B, Sikole A, Rakhorst G, Graaff R.

Eur J Clin Nutr. 2015 Mar;69(3):410. doi: 10.1038/ejcn.2015.14.

PMID:
25735426
19.

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.

Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT.

Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15.

PMID:
25600953
20.

The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients.

Arsov S, Trajceska L, van Oeveren W, Smit AJ, Dzekova P, Stegmayr B, Sikole A, Rakhorst G, Graaff R.

Eur J Clin Nutr. 2015 Mar;69(3):309-13. doi: 10.1038/ejcn.2014.261. Epub 2015 Jan 14. Erratum in: Eur J Clin Nutr. 2015 Mar;69(3):410.

PMID:
25585601

Supplemental Content

Loading ...
Support Center